Zentalis Grants Options for 136,000 Shares to Four New Employees
Zentalis Pharmaceuticals granted stock options covering 136,000 shares to four new employees.
Related stories
Palantir forecasts strong quarterly revenue on AI demand
Palantir forecasts strong quarterly revenue, citing AI demand. The wire also says it raises its annual revenue outlook, but the report is truncated.
M impact | EQUITY | Nov 02, 2026, 11:44 PM UTC
Chile Committee of Ministers Approves San Antonio Port Project
Chile’s Committee of Ministers gave the green light to a project linked to the Port of San Antonio.
M impact | EQUITY | Nov 02, 2026, 11:44 PM UTC
Archrock Reports Quarterly Results for Period Ended September 30
M impact | EQUITY | Nov 02, 2026, 11:43 PM UTC
Palantir Sees Q3 Profit More Than Doubling, Raises 2026 Outlook
Palantir said it expects profit to more than double in the third quarter and raised its projections for 2026; its shares rose.
M impact | EQUITY | Nov 02, 2026, 11:43 PM UTC
New Mountain Finance Reports Quarterly Results Through September 30
A machine-generated LSEG earnings summary covers New Mountain Finance Corp’s quarter ended September 30.
M impact | EQUITY | Nov 02, 2026, 11:43 PM UTC
California Resources Reports Quarterly Results
California Resources Corporation reported results for the quarter ended September 30. The supplied summary contains no financial figures.
M impact | EQUITY | Nov 02, 2026, 11:43 PM UTC